Statement Of Cash Flows [Abstract]

Medistim - Filing #2583905

Concept 2022-01-01 to
2022-12-31
As at
2022-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
113 491 NOK
127 374 NOK
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
9 251 NOK
7 403 NOK
Cash flows from (used in) investing activities
21 102 NOK
11 486 NOK
Cash flows from (used in) financing activities [abstract]
Repayments of borrowings, classified as financing activities
- NOK
4 500 NOK
Payments of lease liabilities, classified as financing activities
7 312 NOK
7 502 NOK
Dividends paid, classified as financing activities
68 396 NOK
54 640 NOK
Other inflows (outflows) of cash, classified as financing activities
5 404 NOK
7 589 NOK
Cash flows from (used in) financing activities
70 304 NOK
59 053 NOK
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
1 066 NOK
764,000 NOK
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
23 151 NOK
57 599 NOK
Cash and cash equivalents
144 164 NOK
124 866 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.